7-8 November, Alma Aty, Kazakhstan. International Scientific Forum “Innovations in Healthcare” IH 2019 is taking being held by Medical Centre of Administration of President of Republic of Kazakhstan these days with support of National Academy of Science. The key topics are “Accessible Future Medicine. Trends and Outlooks” and “Personalised Medicine”. Ai Mediq is honoured to be invited to this important event dedicated to the most…
On 17th and 18th of October, National Research Center for Obstetrics, Gynaecology and Perinatology named after Academician V.I. Kulakov has hosted a Forum Productive Longevity: Evidence-Based Medicine and Transdisciplinary Synthesis.
On 17th of October Luxinnovations has held an event “Horizon 2020 day 2019” dedicated to the past successes of Innovative industries of Luxembourg in their pan-European collaboration under the Horizon 2020 program.
We are very pleased to congratulate Gregg L. Semenza, William G. Kaelin Jr., Sir Peter J. Ratcliffe – our colleagues in the area of hypoxia research, with the highest scientific achievement: the Nobel Prize in Physiology or Medicine! Their discoveries of how cells sense and adapt to oxygen availability, and identification of the “molecular machinery that regulates genes activity in response to varying levels of…
On 27th of September Center for Sports Medicine and Rehabilitation PROSPORT, located in the village of Ryskulova (Almaty region, Talgar district) has hosted an international conference “Multidisciplinary approach to medical support in the system of elite athletes training”.
Ai Mediq took part at the conference “Bringing innovation to the health tech market” hosted by Luxinnovation on 19 September 2019. The key question being discussed at the conference were Regulatory aspects.
Ai Mediq took part in the Congress of European Society of Cardiology 2019 in Paris, France. This year Ai Mediq has had detailed feedback from key opinion leaders and are looking into possible options to introduce ReOxy, our core product, to rehabilitation of chronic heart failure patients
Ai Mediq is looking forward to seeing all our existing partners and new potential collaborators at joint booth of Ministry of Economy of Grand Duchy of Luxembourg. The booth number remained the same A74 in Hall 3, so you should have no problems locating us. See you in Dusseldorf. P.S. Distributors wanted.
Last Friday (26th of July 2019) one of the most recent clinical trials involving ReOxy has been registered with CliniclTrials.gov database with NCT04034082 identifier.
Ai Mediq is pleased to announce approval of new clinical trial named “Evaluation of clinical efficacy of interval hypoxic-hyperoxic trainings in treatment of patients with reduced ejection fraction of left ventricle (2-3 NYHA)
